瞬时弹性成像数据联合APRI检测和分期囊性纤维化儿童肝病的准确性
该横断面研究在澳大利亚三级儿科中心连续纳入160例囊性纤维化儿童,评估瞬时弹性成像(TE)联合天冬氨酸氨基转移酶与血小板比率指数(APRI)检测囊性纤维化相关肝病(CFLD)及分期的准确性。结果显示,肝硬度测量值(LSM)联合APRI检测CFLD的AUROC为0.89,区分F3-F4与F1-F2纤维化的AUROC为0.92。
要点
- LSM在86%的儿童中可可靠测量,诊断准确性随年龄增加。
- LSM联合APRI检测CFLD的AUROC为0.89,灵敏度87%,特异度74%。
- LSM联合APRI区分F3-F4与F1-F2纤维化的AUROC为0.92,灵敏度83%,特异度100%。
核心结论
- TE测量的LSM能准确检测囊性纤维化儿童的肝病,联合APRI可提高诊断准确性。
- LSM还能区分囊性纤维化儿童的轻中度纤维化与晚期纤维化。
研究设计与样本
- 横断面研究,2011年至2016年在澳大利亚一家三级儿科转诊中心连续纳入160例囊性纤维化儿童(年龄9.0±0.4岁,53%为男性)。
- 根据临床、生化和影像学特征将患者分为囊性纤维化相关肝病(CFLD)组或无肝病的囊性纤维化(CFnoLD)组。
- CFLD患儿的纤维化严重程度以双针肝活检的组织学分析为参考标准确定。
- 无囊性纤维化的健康儿童(n=64,对照)数据来自另一项独立研究。
主要发现
- LSM在86%的儿童中可可靠测量,准确性随年龄增加。
- CFLD组LSM为10.7±2.4 kPa(n=33),高于CFnoLD组的4.6±0.1 kPa(n=105)(P<.0001),也高于对照组的4.1±0.1 kPa(P<.0001)。
- CFnoLD组LSM高于对照组(P<.05)。
- 以5.55 kPa为界值,LSM识别CFLD的AUROC为0.82,灵敏度70%,特异度82%(P<.0001)。
- 联合LSM和APRI的分类回归树模型识别CFLD的AUROC为0.89,灵敏度87%,特异度74%(比值比18.6)。
关键数值与推荐
- LSM界值5.55 kPa:识别CFLD的AUROC 0.82,灵敏度70%,特异度82%。
- LSM联合APRI:识别CFLD的AUROC 0.89,灵敏度87%,特异度74%,比值比18.6。
- LSM界值8.7 kPa:区分F3-F4期与F1-F2期纤维化的AUROC 0.87,灵敏度75%,特异度100%。
- LSM联合APRI:区分F3-F4期与F1-F2期纤维化的AUROC 0.92,灵敏度83%,特异度100%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Liver disease develops in 15%-72% of patients with cystic fibrosis, and 5%-10% develop cirrhosis or portal hypertension, usually during childhood. Transient elastography (TE) is a noninvasive method to measure liver stiffness. We aimed to validate its accuracy in detection of liver disease and assessment of fibrosis in children with cystic fibrosis. METHODS: We performed a cross-sectional study to evaluate the accuracy of TE in analysis of liver disease in 160 consecutive children who presented with cystic fibrosis (9.0 ± 0.4 years old, 53% male) at a tertiary referral pediatric center in Australia, from 2011 through 2016. Patients were classified as having cystic fibrosis-associated liver disease (CFLD) or cystic fibrosis without liver disease (CFnoLD) based on clinical, biochemical, and imaging features. Fibrosis severity was determined from histologic analysis of dual-pass liver biopsies from children with CFLD, as the reference standard. Data from healthy children without cystic fibrosis (n = 64, controls) were obtained from a separate study. Liver stiffness measurements (LSMs) were made by Fibroscan analysis, using the inter-quartile range/median ≤30% of 10 valid measurements. Children with macronodularity or portal hypertension with heterogeneous changes on ultrasound without available biopsy were assigned to the category of stage F3-F4 fibrosis. RESULTS: LSM was made reliably in 86% of children; accuracy increased with age. LSMs were significantly higher in children with CFLD (10.7 ± 2.4 kPa, n = 33) than with CFnoLD (4.6 ± 0.1 kPa, n = 105) (P < .0001) or controls (4.1 ± 0.1kPa) (P < .0001); LSMs were higher in children with CFnoLD than controls (P < .05). At a cut-off value of 5.55kPa, LSM identified children with CFLD with an area under the receiver operating characteristic (AUROC) curve of 0.82, 70% sensitivity, and 82% specificity (P < .0001). Classification and regression tree models that combined LSM and aspartate aminotransferase to platelet ratio index (APRI) identified children with CFLD with an AUROC curve of 0.89, 87% sensitivity, and 74% specificity (odds ratio, 18.6). LSMs correlated with fibrosis stage in patients with CFLD (r = 0.67, P = .0001). A cut-off value of 8.7kPa differentiated patients with stage F3-F4 fibrosis from patients with stage F1-F2 fibrosis (AUROC, 0.87; 75% sensitivity; 100% specificity, P=.0002). The combination of LSMs and APRI improved the differentiation of patients with F3-F4 fibrosis vs F1-F2 fibrosis (AUROC, 0.92; 83% sensitivity; and 100% specificity (P < .01). CONCLUSIONS: LSMs made by TE accurately detect liver disease in children with cystic fibrosis; diagnostic accuracy increases when LSMs are combined with APRI. LSMs also differentiate between children with cystic fibrosis with mild-moderate fibrosis vs advanced fibrosis.
引用
- Lewindon PJ, Puertolas-Lopez MV, Ramm LE, et al. Accuracy of Transient Elastography Data Combined With APRI in Detection and Staging of Liver Disease in Pediatric Patients With Cystic Fibrosis. Clin Gastroenterol Hepatol. 2019. PMID: 30880274. doi:10.1016/j.cgh.2019.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。